Phase II study of 5-(3,3-bis(2-chloroethyl)-1-triazeno)imidazole-4-carboxamide (NSC-82196) in advanced gastrointestinal cancer.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples